Vertex Pharmaceuticals Market Cap:
17.13B for May 20, 2013Vertex Pharmaceuticals Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 20, 2013 | 17.13B |
| May 17, 2013 | 17.60B |
| May 16, 2013 | 17.24B |
| May 15, 2013 | 17.58B |
| May 14, 2013 | 17.94B |
| May 13, 2013 | 17.75B |
| May 10, 2013 | 17.81B |
| May 9, 2013 | 17.00B |
| May 8, 2013 | 16.70B |
| May 7, 2013 | 16.92B |
| May 6, 2013 | 17.10B |
| May 3, 2013 | 16.82B |
| May 2, 2013 | 17.21B |
| May 1, 2013 | 17.01B |
| April 30, 2013 | 17.01B |
| April 29, 2013 | 17.34B |
| April 26, 2013 | 17.50B |
| April 25, 2013 | 17.56B |
| April 24, 2013 | 17.72B |
| April 23, 2013 | 18.26B |
| April 22, 2013 | 18.00B |
| April 19, 2013 | 18.72B |
| April 18, 2013 | 11.56B |
| April 17, 2013 | 11.82B |
| April 16, 2013 | 11.89B |
| April 15, 2013 | 11.82B |
| April 12, 2013 | 12.19B |
| April 11, 2013 | 11.99B |
| April 10, 2013 | 11.99B |
| April 9, 2013 | 11.50B |
| April 8, 2013 | 11.53B |
| April 5, 2013 | 11.64B |
| April 4, 2013 | 11.58B |
| April 3, 2013 | 11.51B |
| April 2, 2013 | 11.79B |
| April 1, 2013 | 11.81B |
| March 28, 2013 | 11.99B |
| March 27, 2013 | 11.96B |
| March 26, 2013 | 11.86B |
| March 25, 2013 | 11.84B |
| March 22, 2013 | 11.73B |
| March 21, 2013 | 11.40B |
| March 20, 2013 | 11.45B |
| March 19, 2013 | 11.32B |
| March 18, 2013 | 11.21B |
| March 15, 2013 | 11.41B |
| March 14, 2013 | 11.52B |
| March 13, 2013 | 11.51B |
| March 12, 2013 | 11.44B |
| March 11, 2013 | 11.47B |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
VRTX Market Cap Benchmarks
| Companies | |
|---|---|
| Cleveland BioLabs | 72.34M |
| Gilead Sciences | 85.02B |
| Merck | 139.00B |
VRTX Market Cap Rankings
| Overall |
95th percentile 359 of 8002 |
| Sector |
94th percentile 36 of 684 in Healthcare |
| Industry |
96th percentile 9 of 248 in Biotechnology |
VRTX Market Cap Range, Past 5 Years
| Minimum | 3.118B | Oct 28 2008 |
| Maximum | 18.72B | Apr 19 2013 |
| Average | 7.922B |